There are no effective treatments for millions of patients with intractable epilepsy. High-fat ketogenic diets may provide significant clinical benefit but are challenging to implement. Low carbohydrate levels appear to be essential for the ketogenic diet to work, but the active ingredients in dietary interventions remain elusive, and a role for ketogenesis has been challenged. A potential antiseizure role of dietary protein or of individual amino acids in the ketogenic diet is understudied. We investigated the two exclusively ketogenic amino acids, L-leucine and L-lysine, and found that only L-leucine potently protects mice when administered prior to the onset of seizures induced by kainic acid injection, but not by inducing ketosis. Unexpectedly, the D-enantiomer of leucine, which is found in trace amounts in the brain, worked as well or better than L-leucine against both kainic acid and 6 Hz electroshock-induced seizures. However, unlike L-leucine, D-leucine potently terminated seizures even after the onset of seizure activity. Furthermore, D-leucine, but not L-leucine, reduced long-term potentiation but had no effect on basal synaptic transmission in vitro. In a screen of candidate neuronal receptors, D-leucine failed to compete for binding by cognate ligands, potentially suggesting a novel target. Even at low doses, D-leucine suppressed ongoing seizures at least as effectively as diazepam but without sedative effects. These studies raise the possibility that D-leucine may represent a new class of anti-seizure agents, and that D-leucine may have a previously unknown function in eukaryotes.
Introduction
Approximately one million people in the US have seizures that are not controlled by appropriately-chosen medications (Brodie et al., 2012; Kobau et al., 2008; Kwan and Brodie, 2000) . However, the efficacy of epilepsy medications has not improved substantially in the past 50 years. One underutilized option for these patients is metabolismbased therapy (Hartman and Stafstrom, 2013) , with the high-fat, lowcarbohydrate ketogenic diet being the most widely used form (Hartman et al., 2007; Neal et al., 2008) . However, the full benefit of the ketogenic diet is hampered by difficulties with implementation. Efforts to decipher the mechanisms of action have focused primarily on fatty acid metabolites and carbohydrate restriction (Masino and Rho, 2012) . The other relevant ketogenic diet component is protein, which is minimized to induce systemic ketosis (Hartman and Vining, 2007; Laeger et al., 2014) . Thus, the possibility that proteins or their amino acid components could actively contribute to efficacy of the ketogenic diet seems counterintuitive. Furthermore, free amino acids potently stimulate the nutrient-sensing kinase mTORC1 (mammalian target of rapamycin complex 1), which is already hyperactive in epilepsy patients with mutations in TSC1/2 (tuberous sclerosis complex) (Orlova and Crino, 2010) . In addition, mTOR activity is elevated in rodent brains following kainic acid-induced seizures (Zeng et al., 2009) . However, the role of mTOR in other epilepsy etiologies is not understood, and our studies of wild type mice indicate that the mTOR inhibitor rapamycin has minimal or no benefit in several acute seizure models (Hartman et al., 2012) .
In addition to its role in nutrient signaling to mTORC1 (Bar-Peled and Sabatini, 2014; Cota et al., 2006; Sancak et al., 2008) , L-leucine is a ketogenic amino acid, in that its degradation results in the production of ketone bodies, particularly acetoacetate and its metabolite β-hydroxybutyrate, both of which have been implicated as anticonvulsants (Bixel and Hamprecht, 1995; Masino and Rho, 2012) . However, elevated L-leucine and other branched-chain amino acids have been associated with abnormal developmental outcomes and seizures (Mackenzie and Woolf, 1959; Menkes et al., 1954) , dampening the exploration of potentially efficacious amino acids. We tested the ketogenic amino acid L-leucine in mice and found striking protection against seizure activity, but without evidence of elevated blood ketones. Remarkably, the enantiomer D-leucine was a more potent anti-seizure 
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